Open access
Aug 2026
Differential Effectiveness of Adjuvant Endocrine Therapy According to Menopausal Status, Body Mass Index, and Molecular Subtype in Hormone Receptor-Positive Breast Cancer
The association between adjuvant endocrine therapy and BC-specific mortality differed according to menopausal status, BMI, and molecular subtype, suggesting that menopausal status, BMI, and molecular subtype are important considerations when evaluating endocrine treatment strategies.
J. Koh, You-Jin Hong, Eun Ji Sim et al.
· Journal of Breast Cancer · 0 citations